Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors
Articolo
Data di Pubblicazione:
2023
Citazione:
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors / D. Moi, S. Vittorio, A. Angeli, G. Balboni, C.T. Supuran, V. Onnis. - In: MOLECULES. - ISSN 1420-3049. - 28:1(2023 Jan), pp. 91.1-91.19. [10.3390/molecules28010091]
Abstract:
A small series of hydrazonobenzenesulfonamides was designed, synthesized and studied for their human carbonic anhydrase (hCA) inhibitory activity. The synthesized compounds were evaluated against hCA I, II, IX and XII isoforms using acetazolamide (AAZ) as the standard inhibitor. Various hydrazonosulfonamide derivatives showed inhibitory activity at low nanomolar levels with selectivity against the cytosolic hCA II isoform, as well as the transmembrane, tumor-associated enzymes hCA IX and XII. The most potent and selective hydrazones 8, 9, 10, 11, 19 and 24 were docked into isoforms I, II, IX and XII to better understand their activity and selectivity for the different CA isoforms.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
sulfonamides; hydrazones; carbonic anhydrase enzyme inhibition
Elenco autori:
D. Moi, S. Vittorio, A. Angeli, G. Balboni, C.T. Supuran, V. Onnis
Link alla scheda completa: